A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging
- PMID: 18256261
- PMCID: PMC2902235
- DOI: 10.1523/JNEUROSCI.4098-07.2008
A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging
Abstract
Alzheimer's disease (AD) is a debilitating neurodegenerative disorder affecting millions of elderly individuals worldwide. Advances in the genetics of AD have led to new levels of understanding and treatment opportunities. Here, we used a systems biology approach based on weighted gene coexpression network analysis to determine transcriptional networks in AD. This method permits a higher order depiction of gene expression relationships and identifies modules of coexpressed genes that are functionally related, rather than producing massive gene lists. Using this framework, we characterized the transcriptional network in AD, identifying 12 distinct modules related to synaptic and metabolic processes, immune response, and white matter, nine of which were related to disease progression. We further examined the association of gene expression changes with progression of AD and normal aging, and were able to compare functional modules of genes defined in both conditions. Two biologically relevant modules were conserved between AD and aging, one related to mitochondrial processes such as energy metabolism, and the other related to synaptic plasticity. We also identified several genes that were central, or hub, genes in both aging and AD, including the highly abundant signaling molecule 14.3.3 zeta (YWHAZ), whose role in AD and aging is uncharacterized. Finally, we found that presenilin 1 (PSEN1) is highly coexpressed with canonical myelin proteins, suggesting a role for PSEN1 in aspects of glial-neuronal interactions related to neurodegenerative processes.
Figures
Similar articles
-
Hippocampal gene expression patterns linked to late-life physical activity oppose age and AD-related transcriptional decline.Neurobiol Aging. 2019 Jun;78:142-154. doi: 10.1016/j.neurobiolaging.2019.02.012. Epub 2019 Feb 20. Neurobiol Aging. 2019. PMID: 30927700 Free PMC article.
-
Accelerated brain aging towards transcriptional inversion in a zebrafish model of the K115fs mutation of human PSEN2.PLoS One. 2020 Jan 24;15(1):e0227258. doi: 10.1371/journal.pone.0227258. eCollection 2020. PLoS One. 2020. PMID: 31978074 Free PMC article.
-
Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways.Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12698-703. doi: 10.1073/pnas.0914257107. Epub 2010 Jun 25. Proc Natl Acad Sci U S A. 2010. PMID: 20616000 Free PMC article.
-
Genetic influences on white matter and metabolism abnormal change in Alzheimer's disease: Meta-analysis for neuroimaging research on presenilin 1 mutation.Clin Neurol Neurosurg. 2019 Feb;177:47-53. doi: 10.1016/j.clineuro.2018.12.016. Epub 2018 Dec 26. Clin Neurol Neurosurg. 2019. PMID: 30599314 Review.
-
Transcriptional regulation of the presenilin-1 gene: implication in Alzheimer's disease.Front Biosci. 2008 Jan 1;13:822-32. doi: 10.2741/2723. Front Biosci. 2008. PMID: 17981591 Review.
Cited by
-
Systems genetic analysis of osteoblast-lineage cells.PLoS Genet. 2012;8(12):e1003150. doi: 10.1371/journal.pgen.1003150. Epub 2012 Dec 27. PLoS Genet. 2012. PMID: 23300464 Free PMC article.
-
Glucocorticoid-dependent hippocampal transcriptome in male rats: pathway-specific alterations with aging.Endocrinology. 2013 Aug;154(8):2807-20. doi: 10.1210/en.2013-1139. Epub 2013 Jun 4. Endocrinology. 2013. PMID: 23736296 Free PMC article.
-
MicroRNAs as Diagnostic and Prognostic Biomarkers in Ischemic Stroke-A Comprehensive Review and Bioinformatic Analysis.Cells. 2018 Dec 6;7(12):249. doi: 10.3390/cells7120249. Cells. 2018. PMID: 30563269 Free PMC article. Review.
-
GJA1 (connexin43) is a key regulator of Alzheimer's disease pathogenesis.Acta Neuropathol Commun. 2018 Dec 21;6(1):144. doi: 10.1186/s40478-018-0642-x. Acta Neuropathol Commun. 2018. PMID: 30577786 Free PMC article.
-
Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies.Neurobiol Dis. 2021 Dec;160:105530. doi: 10.1016/j.nbd.2021.105530. Epub 2021 Oct 9. Neurobiol Dis. 2021. PMID: 34634459 Free PMC article. Review.
References
-
- Aitken A. 14-3-3 proteins: a historic overview. Semin Cancer Biol. 2006;16:162–172. - PubMed
-
- Arendt T. Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. Neurobiol Aging. 2000;21:783–796. - PubMed
-
- Arendt T. Neurodegeneration and plasticity. Int J Dev Neurosci. 2004;22:507–514. - PubMed
-
- Baldi P, Long A. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics. 2001;17:509–519. - PubMed
-
- Barabasi A, Oltvai Z. Network biology: understanding the cell's functional organization. Nat Rev Genet. 2004;5:101–113. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical